首页|高通量测序技术在粪便菌群移植中的应用

高通量测序技术在粪便菌群移植中的应用

扫码查看
粪便菌群移植(FMT)作为目前治疗肠道菌群失调最为有效的手段,在艰难梭菌感染、炎症性肠病、肠易激综合征等疾病治疗方面发挥着重要作用.目前,RBX2660、Vowst等粪便微生物药物已获得美国食品药品监督管理局批准上市.高通量测序技术作为一项飞速发展的新技术,可通过扩增肠道菌群可变区的特定区段,分析菌群的组成、丰度等信息,为FMT过程中的供体选择、受体特征分析、效果监测等环节提供强有力的工具.高通量测序技术的应用可有力推动FMT的粪便制备过程质量控制、功能微生物确定、效果监测等方面的发展.本文旨在阐述和总结高通量测序技术在FMT领域的应用前景以及未来的发展趋势.
Application of High-Throughput Sequencing Technology in Fecal Microbiota Transplantation
Fecal microbiota transplantation(FMT)is currently one of the most effective treatments for diseases associated with intestinal dysbiosis,such as Clostridium difficile infection,inflammatory bowel disease and irritable bowel syndrome.At present,fecal microbiota drugs such as RBX2660 and Vowst have been approved for market by the U.S.Food and Drug Administration.High-throughput sequencing technology,as a rapidly developing new technology,can analyze the composition and abundance of microbiome by amplifying specific regions of gut microbiota,providing a powerful tool for donor selection,recipient characterization,and monitoring of FMT effect during the FMT procedure.The application of high-throughput sequencing technology can significantly promote quality control during fecal preparation for FMT,identification of functional microorganisms,and long-term monitoring of FMT effect.Therefore,this review aims to summarize the applications of high-throughput sequencing technology in the field of FMT and its future development trends.

fecal microbiota transplantationhigh-throughput sequencing technologygut microbiotaapplicationchallenge

李曼郁、刘东来、周海卫

展开 >

中国食品药品检定研究院体外诊断试剂检定所传染病诊断试剂一室

国家药品监督管理局医疗器械质量研究与评价重点实验室

国家药品监督管理局体外诊断试剂质量研究与评价重点实验室

中国食品药品检定研究院体外诊断试剂检定所传染病诊断试剂二室

展开 >

粪便菌群移植 高通量测序技术 肠道菌群 应用 挑战

2024

中国食品药品监管
中国医药报社

中国食品药品监管

影响因子:0.099
ISSN:1673-5390
年,卷(期):2024.(4)
  • 59